Journal
AMERICAN JOURNAL OF CARDIOLOGY
Volume 89, Issue 3, Pages 318-+Publisher
EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
DOI: 10.1016/S0002-9149(01)02232-9
Keywords
-
Categories
Ask authors/readers for more resources
Troglitazone reduced in-stent restenosis and target lesion revascularization after coronary stent implantation using 2.5-mm stents in type 2 diabetic patients. Serial intravascular ultrasound assessment demonstrated that the reduction in neointimal tissue proliferation in the troglitazone group is associated with angiographic benefits.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available